Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-18

Clinical Trial Update: Tirzepatide for the Treatment of Cannabis Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tirzepatide for cannabis use disorder has been announced and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirzepatide (tirzepatide)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Cannabis Use Disorder | Phase 2 | Status: NOT_YET_RECRUITING